Cargando…
Managing Active Iupus Nephritis During COVID-19 Pandemic
India is seeing a rapid rise in coronavirus disease-2019 (COVID-19). Immunosuppression is a possible risk factor for severe COVID-19, although their exact interaction is unclear. A total of 13 cases with active lupus nephritis (LN, with or without extra-renal manifestations) were managed with intens...
Autores principales: | Bharati, Joyita, Rathi, Manish, Ramachandran, Raja, Sharma, Aman, Nada, Ritambhra, Kohli, Harbir S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443088/ https://www.ncbi.nlm.nih.gov/pubmed/34584357 http://dx.doi.org/10.4103/ijn.IJN_301_20 |
Ejemplares similares
-
Anti-Nuclear Antibody-Negative Lupus Nephritis or Post-Infectious Glomerulonephritis: Diagnostic Dilemma in a Young Male
por: Bharati, Joyita, et al.
Publicado: (2021) -
Complete Remission of Lupus Nephritis Following Chemoradiotherapy of Carcinoma Cervix: An Association
por: Girimaji, Niveditha, et al.
Publicado: (2021) -
Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
por: Bharati, Joyita, et al.
Publicado: (2019) -
Contribution of Clinically Indicated Repeat Renal Biopsy in Indian Patients with Lupus Nephritis
por: Gupta, Krishan L., et al.
Publicado: (2020) -
Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy
por: Bharati, Joyita, et al.
Publicado: (2018)